Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China's Tahoe Offers $75 Million to Privatize Alliance Healthcare

publication date: Apr 14, 2017
Tahoe Investment Group (formerly known as Fujian Thai Hot) is offering $75 million to privatize Alliance HealthCare, a US provider of outsourced radiology, oncology and interventional services. One year ago, Tahoe paid $102.5 million for a majority 51.5% stake in Alliance. At the time of its original Alliance acquisition, Tahoe said its goal was to expand Alliance's services into China. In December 2016, Tahoe offered $54 million to purchase the remaining shares, but has now upped its bid to $75 million, a 69% premium over December's pre-offer stock price. More details....

Stock Symbol: (NSDQ: AIQ)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital